Oric

Apr 02, 2020

ORIC Pharmaceuticals Appoints Christian V. Kuhlen, M.D., as General Counsel

Mar 02, 2020

ORIC Pharmaceuticals Appoints Mardi C. Dier to its Board of Directors

Jan 02, 2020

ORIC Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference

Dec 02, 2019

ORIC Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference

Jul 09, 2019

ORIC Pharmaceuticals Appoints Lori Friedman, PhD, as Chief Scientific Officer

Apr 02, 2019

ORIC Pharmaceuticals Presents Evidence of Glucocorticoid Receptor-Mediated Cancer Treatment Resistance at the AACR Annual Meeting

Mar 04, 2019

ORIC Pharmaceuticals Appoints Edna Chow Maneval, PhD, as Senior Vice President of Clinical Development

Feb 20, 2019

ORIC Pharmaceuticals to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

Nov 26, 2018

ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer

Nov 19, 2018

ORIC Pharmaceuticals to Present at Upcoming Investor Conferences

Oct 22, 2018

ORIC to Participate at BTIG Biotech Conference

Sep 17, 2018

ORIC Pharmaceuticals Appoints Pratik Multani, MD, as Chief Medical Officer

Aug 30, 2018

ORIC to Participate at Citi 13th Annual Biotech Investor Conference

Dec 20, 2017

ORIC Has Appointed Rich Heyman, PhD as Acting Chief Executive Officer and Leonard Reyno, MD as Chief Medical Officer

Oct 27, 2017

ORIC Pharmaceuticals Announces First Subject Dosed in Phase 1 Clinical Study of Novel GR Antagonist with Planned Development for Oncology